HOME >> BIOLOGY >> NEWS
New imaging technology at Joslin shown to detect early signs of type 1 diabetes

BOSTON - By the time overt symptoms of type 1 diabetes appear in an individual, destruction of the insulin-producing beta cells of the pancreas has already progressed significantly. However, findings by researchers at Joslin Diabetes Center and Massachusetts General Hospital, published in the Aug. 24 issue of Proceedings of the National Academy of Sciences, show that a powerful new imaging technology gives scientists a glimpse into the earliest stages of the inflammatory process leading to type 1 diabetes in laboratory animals. The new findings one day may be useful for predicting whether and when diabetes will develop in humans.

Type 1 diabetes is an autoimmune disease in which the body's immune system mistakenly launches an attack on the insulin-producing beta cells of the pancreatic islets. This process may eventually destroy the beta cells, preventing them from producing sufficient insulin, so that high blood-glucose levels--and full-blown diabetes--develop. Early in this process, white blood cells called T-cells invade the islets (an inflammatory condition known as "insulitis"). A very early marker of this inflammation is increased permeability (leaking) of the tiny blood vessels surrounding and within the islets.

Until recently, the only way to track type 1 diabetes in its earliest stages was to measure blood levels of autoantibodies (the immune system's "guided missiles") directed against pancreatic islet proteins. Yet, these tests are only an indirect indication of the disease process, and don't allow researchers to directly follow the progression of disease.

This gap may someday be filled by a new technology that exploits magnetic resonance imaging, commonly known as MRI, to monitor miniscule magnetic nanoparticles leaking from the blood vessels of the pancreas, according to Maria Denis, Ph.D., Christophe Benoist, M.D., Ph.D., and Diane Mathis, Ph.D., of Joslin Diabetes Center, and Umar Mahmood, M.D., Ph.D.
'"/>


1-Sep-2004


Page: 1 2

Related biology news :

1. Trojan Horses, xenon imaging and remote controlled genes
2. Small animal imaging gives cancer clues
3. Computer imaging of Archeopteryx skull suggests this dinosaur-bird link could fly
4. Innovative efforts target epigenetics, molecular imaging
5. Carnegie Mellon U. imaging study reveals sex-based differences that persist as mice enter adulthood
6. Whole body imaging allows better understanding of the immune system
7. 3-D micro-imaging technology licensed to Carl Zeiss Jena
8. SPECT imaging shows promise for accurate, early diagnosis of Alzheimers
9. New imaging technique developed to identify breast cancer
10. Carnegie Mellon enhances Quantum Dot Corp. technology for long-term, live-animal imaging
11. Combining various magnetic resonance imaging techniques may help improve breast cancer detection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... TORONTO (PRWEB) , ... June 22, 2020 , ... The ... time. Typically, ligand binding assays (LBA) have dominated this area. However, the use of ... several years. , This now necessitates the question “How do you choose which approach ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... In its ... feature interview with Dr. James L. Sherley, M.D., Ph.D., founder and director of ... the company announced on June 16 that starting July 5 it would ...
(Date:6/19/2020)... ... June 18, 2020 , ... ... Your Lab with Software for Data Decisions,” for pharmaceutical and biotech executives, ... integrate and automate cutting-edge scientific instruments and laboratory equipment from dozens of ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... The ... centers in 16 countries, has reached its 20th anniversary of worldwide use. Introduced ... use at top universities including University of Pennsylvania, University of Michigan, University of ...
(Date:7/18/2020)... DAYTON, Ohio (PRWEB) , ... July 16, 2020 ... ... clinical data solutions to aid in the early detection and prevention of high-burden ... partnership to enable US-based hospitals and healthcare organizations to utilize existing data in ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... ... to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., ... and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson ...
(Date:7/1/2020)... ... June 30, 2020 , ... Flagship ... of a new clinical diagnostics immuno-oncology service, TissueInsight . TissueInsight provides ... “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists in ...
Breaking Biology Technology:
Cached News: